ArticleFrontiers in pharmacology2025
Exercise ameliorates hepatic lipid accumulation via upregulating serum PRL and activating hepatic PRLR-mediated JAK2/STAT5 signaling pathway in NAFLD mice.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): New Perspectives on an Evolving Epidemic.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Non alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases, closely related to overnutrition, obesity, and metabolic syndrome. This study used exercise intervention on NAFLD mice to investigate the effect of aerobic exercise on NAFLD. Method: After one week of acclimatization, the mice were randomly divided into two groups: a control group (C group, n = 14) fed a standard diet and a model group (M group, n = 24) fed a high-fat diet. At the end of the 10th week, four mice from each group were randomly selected for liver pathological sectioning and Oil Red O staining to assess hepatic lipid droplet formation and confirm the successful establishment of the NAFLD model. Subsequently, the remaining mice in M group were further randomized into two subgroups: a model control group (CM group, n = 10) and a model exercise group (EM group, n = 10). After modeling, the blood glucose tolerance of mice, HE staining and red oil staining of liver tissue, HDL-C, LDL, TC, TG, AST, ALT, PRL content in serum, and JAK, PRLR, STAT5 content in liver were detected. Result: The glucose tolerance test found that at 10 and 30 minutes, compared with the C group, the blood glucose level in the CM group increased (P < 0.05), while the blood glucose level in the EM group decreased compared to the CM group (P < 0.05); After 60 minutes, there was no statistically significant difference in blood glucose levels among the groups of rats compared to C group, the final body weight of CM group and EM group was significantly higher (P < 0.01). The final body weight of EM group was significantly lower than that of CM group (P < 0.01). In terms of liver index, both C group and EM group showed significantly lower values than CM group (P < 0.01). Compared to C group, both CM group and EM group exhibited significantly higher levels of TC and LDL-C (P < 0.01) whereas HDL-C levels were significantly lower in CM group (P < 0.01). When compared to CM group, EM group showed significantly reduced LDL-C levels (P < 0.01), while HDL-C levels were significantly higher (P < 0.01). Compared with group C, there were significant differences in serum AST, ALT, and PRL levels in the CM group (P < 0.01). There were significant differences in serum AST, ALT, and PRL levels between the EM group and the CM group (P < 0.05).The gene testing results of JAK and STAT5a showed no statistical difference in expression among the three groups. The PRLR gene results showed that compared with the C group, the PRLR in the CM group was significantly reduced (p < 0.01); Compared with the CM group, the PRLR in the CE group was significantly increased (p < 0.01). Compared with group C, the expression levels of PRLR and p-STAT5 were significantly reduced in both CM and EM groups (p < 0.01). The p-JAK2 levels in the CM group were significantly reduced compared to the C group (p < 0.01). The expression levels of PRLR, p-JAK2, and p-STAT5 in the EM group were significantly higher than those in the CM group (p < 0.01). Conclusion: Exercise may moderately elevate serum prolactin (PRL) levels, thereby reducing intrahepatic lipid accumulation and ameliorating non-alcoholic fatty liver disease (NAFLD). The underlying mechanism may involve upregulation of the hepatic classical PRLR-mediated JAK2/STAT5 signaling pathway.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.